August 2014
Synthesis and Optical Properties on Novel Fluorescence-Traced Benzimidazolium Bromides
E75
CH3), 1.31–1.25 (m, 2H, CH2), 1.83–1.77 (m, 2H, CH2), 2.44
(s, 3H, CH3), 4.22 (t, J = 7.65Hz, 2H, CH2), 7.30–7.27 (m, 4H,
Ar-H), 7.41–7.39 (m, 1H, Ar-H), 7.61 (d, J = 8.1Hz, 2H, Ar-H),
7.83–7.81 (m, 1H, Ar-H); MS: m/z 265.2 (M + H+), 266.2
(M+ 2H+). Anal. Calcd for C18H20N2: C, 81.78; H, 7.63; N,
10.60. Found: C, 81.75; H, 7.61; N, 10.63.
J = 15.39Hz, 1H, CH2═), 5.34 (d, J = 10.38Hz, 1H, CH2═),
6.03–5.98 (m, 1H, -CH═), 7.74–7.41 (m, 6H, Ar-H), 7.93–7.84
(m, 2H, Ar-H), 8.00 (d, J = 7.47 Hz, 1H, Ar-H); MS: m/z: 261.3
[MÀ Br]+. Anal. Calcd for C18H19BrN2: C, 62.98; H, 5.58; N,
8.16. Found: C, 62.96; H, 5.60; N, 8.19.
1-Ethyl-2-(4-methylphenyl)-3-allyl-1H-benzimidazolium bromide
1
(5b). Yield: 92.4%; white crystals; mp >310ꢀC; H-NMR (D2O,
1-Ethyl-2-(4-bromophenyl)benzimidazole (4d). Compound
4d was obtained from 2-(4-bromophenyl)-1H-benzimidazole
(3c) and ethyl bromide. Yellow crystal; mp 137–138ꢀC; yield:
500 MHz, ppm): d 1.47 (t, J= 7.15 Hz, 3H, CH3), 2.54 (s, 3H, CH3),
4.43–4.39 (q, J=7.15Hz, 2H, CH2), 4.95 (d, J= 3.95 Hz, 2H, CH2),
5.12 (d, J=17.25Hz, 1H, CH2═), 5.34 (d, J= 10.5 Hz, 1H, CH2═),
6.06–6.00 (m, 1H, -CH═), 7.67–7.62 (m, 4H, Ar-H), 7.79–7.74
(m, 2H, Ar-H), 7.91 (d, J= 7.75 Hz, 1H, Ar-H), 8.00 (d, J=7.85Hz,
1H, Ar-H); MS: m/z: 277.3 [MÀ Br]+. Anal. Calcd for C19H21BrN2:
C, 63.87; H, 5.92; N, 7.84. Found: C, 63.84; H, 5.93; N, 8.21.
1-Butyl-2-(4-methylphenyl)-3-allyl-1H-benzimidazolium bromide
(5c). Yield: 90.3%; yellow crystals; mp >310ꢀC; 1H-NMR (CDCl3,
300 MHz, ppm): d 0.84 (t, J=7.35Hz, 3H, CH3), 1.33–1.28
(m, 2H, CH2), 1.89–1.83 (m, 2H, CH2), 2.52 (s, 3H, CH3),
4.47–4.42 (t, J=7.47Hz, 2H, CH2), 5.06 (d, J=4.14Hz, 2H, CH2),
5.17 (d, J= 17.13 Hz, 1H, CH2═), 5.35 (d, J= 10.17 Hz, 1H,
CH2═), 6.07–5.94 (m, 1H, -CH═), 7.52–7.49 (m, 2H, Ar-H), 7.69–
7.61 (m, 2H, Ar-H), 7.86–7.81 (m, 4H, Ar-H); MS: m/z: 305.1
[M À Br]+. Anal. Calcd for C21H25BrN2: C, 65.46; H, 6.54; N, 7.27.
1
94.8%. H-NMR (CDCl3, 500 MHz, ppm): d 1.44 (t, J = 7.2 Hz,
3H, CH3), 4.25 (q, J = 7.2 Hz, 2H, CH2), 7.33–7.29
(m, 2H, Ar-H), 7.42–7.40 (m, 1H, Ar-H), 7.59 (d, J = 8.15 Hz,
2H, Ar-H), 7.65 (d, J = 8.4 Hz, 2H, Ar-H), 7.83–7.81 (m, 1H,
Ar-H); MS: m/z 301.0 (M + H+), 304.0 (M + 4H+), 323.0
(M + Na+). Anal. Calcd for C15H13BrN2: C, 59.82; H, 4.35; N,
9.30. Found: C, 59.86; H, 4.31; N, 9.35.
1-Butyl-2-(4-bromophenyl)benzimidazole (4e). Compound
4e was obtained from 2-(4-bromophenyl)-1H-benzimidazole (3c)
and n-butyl bromide. Yellow crystal; mp 81–83ꢀC; yield: 93.3%.
1H-NMR (CDCl3, 500 MHz, ppm): d 0.88 (t, J = 7.35Hz, 3H,
CH3), 1.31–1.24 (m, 2H, CH2), 1.82–1.76 (m, 2H, CH2), 4.21
(t, J = 7.65 Hz, 2H, CH2), 7.33–7.29 (m, 2H, Ar-H), 7.47–7.40
(m, 1H, Ar-H), 7.58 (d, J = 8.3 Hz, 2H, Ar-H), 7.65 (d, J = 8.2 Hz,
2H, Ar-H), 7.82–7.80 (m, 1H, Ar-H); MS: m/z 329.1 (M + H+),
332.1 (M+ 4H+), 351.0 (M+ Na+). Anal. Calcd for C17H17BrN2:
C, 62.02; H, 5.20; N, 8.51. Found: C, 62.04; H, 5.19; Br, 24.23;
N, 8.54.
1-Ethyl-2-{4-(9H-carbazole-9-yl)phenyl}benzimidazole (4f).
Compound 4f was obtained from 2-{4-(9H-carbazole-9-yl)
phenyl}-1H-benzimidazole (3d) and ethyl bromide. Yellow
crystal; mp 166–168ꢀC; yield: 88.7%. 1H-NMR (CDCl3,
500 MHz, ppm): d 1.58 (t, J = 7.25 Hz, 3H, CH3), 4.45–4.40
(q, J = 7.25 Hz, 2H, CH2), 7.38–7.30 (m, 4H, Ar-H), 7.51–7.43
(m, 5H, Ar-H), 7.76 (d, J = 8.35 Hz, 2H, Ar-H), 7.89–7.87
(m, 1H, Ar-H), 8.00 (d, J = 8.35 Hz, 2H, Ar-H), 8.16
(d, J = 7.7 Hz, 2H, Ar-H); MS: m/z 388.2 (M + H+), 389.2
(M + 2H+), 410.2 (M + Na+). Anal. Calcd for C27H21N3: C,
83.69; H, 5.46; N, 10.84. Found: C, 83.72; H, 5.44; N, 10.84.
4-(1-Ethyl-1H-benzimidazol-2-yl)-N,N-diaphenylbenzenamine
(4g). Compound 4g was obtained from 4-(N,N-diphenylaminophenyl)-
1H-benzimidazole (3e) and ethyl bromide. Light yellow crystal; mp
170–172ꢀC; yield: 90.2%. 1H-NMR (CDCl3, 300 MHz, ppm):
d 1.48 (t, J=7.17Hz, 3H, CH3), 4.30 (q, J=7.17Hz, 2H, CH2),
7.10–7.05 (m, 2H, Ar-H), 7.24–7.15 (m, 6H, Ar-H), 7.32–7.26
(m, 6H, Ar-H), 7.41–7.38 (m, 1H, Ar-H), 7.59 (d, J=8.46Hz, 2H,
Ar-H), 7.81–7.78 (m, 1H, Ar-H); MS: m/z 390.3 (M + H+), 391.3
(M + 2H+), 412.3 (M + Na+). Anal. Calcd for C27H23N3: C, 83.26;
H, 5.95; N, 10.79. Found: C, 83.28; H, 5.90; N, 10.82.
Procedure for the synthesis of 5a–5g. 1-Alkyl-2-aryl-1H-
benzimidazole (4a–g) (5 mmol) and acetonitrile (20 mL) were
put into a 50-mL four-necked flask and stirred to dissolve. After
heated to 60ꢀC, the mixed liquid of allyl bromide (0.6 g,
5 mmol) and acetonitrile (20 mL) was added dropwise, and the
mixture was heated at refluxing temperature for 24 h. After the
reaction, the mixture was washed with acetonitrile (20 mL)
and then concentrated under reduced pressure to give crude
products. The crude products were purified by recrystallization
from acetonitrile to give pure 5a–g with the following properties:
Found: C, 65.43; H, 6.58; N, 8.20.
1-Ethyl-2-(4-bromophenyl)-3-allyl-1H-benzimidazolium bromide
(5d). Yield: 87.2%; yellow crystals; mp >310ꢀC; 1H-NMR (D2O,
500 MHz, ppm): d 1.43 (t, J= 7.5 Hz, 3H, CH3), 4.40–4.36
(q, J= 7.5 Hz, 2H, CH2), 4.93 (d, J= 4.0 Hz, 2H, CH2), 5.08
(d, J= 16.5 Hz, 1H, CH2═), 5.31 (d, J= 10.5 Hz, 1H, CH2═),
6.02–5.95 (m, 1H, -CH═), 7.65 (d, J= 8.5 Hz, 2H, Ar-H), 7.77–
7.71 (m, 2H, Ar-H), 7.90–7.88 (m, 1H, Ar-H), 7.99–7.94 (m, 3H,
Ar-H); MS: m/z: 341.0 [M À Br]+. Anal. Calcd for C18H18Br2N2: C,
51.21; H, 4.30; N, 6.64. Found: C, 51.25; H, 4.29; N, 6.61.
1-Butyl-2-(4-bromophenyl)-3-allyl-1H-benzimidazolium
bromide (5e).
Yield: 86.3%; yellow crystals; mp >310ꢀC;
1H-NMR (CDCl3, 500 MHz, ppm): d 0.87 (t, J = 7.4 Hz, 3H,
CH3), 1.32–1.23 (m, 2H, CH2), 1.89–1.83 (m, 2H, CH2), 4.39
(t, J = 7.75Hz, 2H, CH2), 5.00 (d, J = 3.45Hz, 2H, CH2), 5.20
(d, J = 17.15 Hz, 1H, CH2═), 5.37 (d, J = 10.45 Hz, 1H, CH2═),
6.05–5.98 (m, 1H, -CH═), 7.68–7.64 (m, 2H, Ar-H), 7.80–7.76
(m, 2H, Ar-H), 7.85 (t, J = 4.20Hz, 2H, Ar-H), 8.04
(d, J = 8.45 Hz, 2H, Ar-H); MS: m/z: 369.0 [MÀ Br]+. Anal.
Calcd for C20H22Br2N2: C, 53.36; H, 4.93; N, 6.22. Found: C,
53.39; H, 4.89; N, 8.22.
1-Ethyl-2-{4-(9H-carbazole-9-yl)phenyl}-3-allyl-1H-
benzimidazolium bromide (5f). Yield: 64.1%; brown crystals;
mp >310ꢀC; 1H-NMR (CD3OD, 500MHz, ppm): d 1.60
(t, J = 7.35Hz, 3H, CH3), 4.57 (q, J = 7.35 Hz, 2H, CH2),
5.12–5.10 (m, 2H, CH2), 8.21–8.20 (m, 2H, Ar-H), 8.14–8.13
(m, 1H, Ar-H), 8.10–8.08 (m, 4H, Ar-H), 5.28 (d, J = 16.95Hz,
1H, CH2═), 5.41 (d, J = 10.5Hz, 1H, CH2═), 6.15–6.09 (m, 1H,
-CH═), 7.37–7.34 (m, 2H, Ar-H), 7.50–7.47 (m, 2H, Ar-H), 7.62
(d, J = 8.25 Hz, 2H, Ar-H), 7.84–7.78 (m, 2H, Ar-H), 8.03–8.02
(m, 1H, Ar-H); MS: m/z: 428.3 [M À Br]+. Anal. Calcd for
C30H26BrN3: C, 70.87; H, 5.15; N, 8.26. Found: C, 70.91; H,
5.16; N, 8.21.
1-Ethyl-2-{(4-N,N-diphenyl)aminophenyl}-3-allyl-1H-
benzimidazolium bromide (5g). Yield: 64.1%; brown crystals;
mp >310ꢀC; 1H-NMR (CD3OD, 500MHz, ppm): d 1.51
(t, J = 7.3 Hz, 3H, CH3), 4.48–4.44 (q, J = 7.3 Hz, 2H, CH2),
5.01–4.99 (m, 2H, CH2), 5.19 (d, J = 17.2Hz, 1H, CH2═), 5.36
(d, J = 10.45Hz, 1H, CH2═), 6.06–6.01 (m, 1H, -CH═),
7.18–7.16 (m, 2H, Ar-H), 7.27–7.23 (m, 6H, Ar-H), 7.44–7.40
1-Ethyl-2-phenyl-3-allyl-1H-benzimidazolium bromide (5a).
Yield: 93.0%; white crystals; mp >310ꢀC; 1H-NMR (D2O,
300 MHz, ppm):
d 1.47 (t, J = 7.05Hz, 3H, CH3), 4.40
(q, J = 7.05 Hz, 2H, CH2), 4.96 (d, J = 3.95Hz, 2H, CH2), 5.12 (d,
Journal of Heterocyclic Chemistry
DOI 10.1002/jhet